Pradaxa/pradax (dabigatran Etexilate) - New Contraindication In Patients With Artificial Heart Valves Requiring Anticoagulant Treatment Due To Their Valvular Status - Notice To Hospitals

Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2012-12-21
Status
Closed
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/8a1127f6-8342-474c-97d0-73ff25b6fed9